BNTGF:OTC-Brenntag AG (USD)

COMMON STOCK | Specialty Chemicals | OTC

Last Closing Price

USD 62.35

Change

0.00 (0.00)%

Market Cap

USD 9.66B

Volume

300.00

Average Target Price

N/A
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. It also provides surfactants, emulsifiers, emollients, waxes, preservatives, silicones, complexing agents, and actives for skin and hair care, sun care, personal hygiene and body cleansing, color cosmetics, and dental and oral care applications; and value-added services. The company serves customers in various end-market industries, including adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals. Brenntag AG was founded in 1874 and is headquartered in Essen, Germany.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-09-26 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
GVDNY Givaudan SA

N/A

USD39.56B 51.31 35.29
GVDBF Givaudan SA

N/A

USD38.18B 50.46 35.29
SXYAY Sika AG

N/A

USD34.10B 49.92 29.12
SKFOF Sika AG

N/A

USD33.85B 47.68 29.12
NPCPF Nippon Paint Holdings Co., Ltd

N/A

USD32.74B 74.09 0.33
KDSKF Koninklijke DSM N.V

N/A

USD27.21B 38.30 25.16
RDSMY Koninklijke DSM N.V

N/A

USD27.02B 38.03 24.90
EMSHF EMS-CHEMIE HOLDING AG

N/A

USD21.08B 42.00 40.41
AKZOF Akzo Nobel N.V

N/A

USD18.84B 38.20 16.97
SYIEY Symrise AG

N/A

USD18.76B 50.66 28.00

ETFs Containing BNTGF

Symbol Name Weight Mer Price(Change) Market Cap
XDGM:LSE Xtrackers Germany Mittels.. 0.00 % 0.40 %

N/A

USD0.07B
C007:XETRA ComStage - MDAX® UCITS E.. 0.00 % 0.30 %

N/A

USD0.17B
F751:XETRA ComStage Alpha Deutschlan.. 0.00 % 0.69 %

N/A

USD0.01B
EXV7:XETRA iShares STOXX Europe 600 .. 0.00 % 0.46 %

N/A

USD0.12B
EXS3:XETRA iShares MDAX UCITS ETF (D.. 0.00 % 0.51 %

N/A

USD1.47B
ELF1:XETRA Deka MDAX UCITS ETF 0.00 % 0.00 %

N/A

USD0.52B
E907:XETRA Lyxor 1 MDAX UCITS ETF 0.00 % 0.30 %

N/A

USD0.11B
C064:XETRA ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

USD0.01B
XDGM:F Xtrackers Germany Mittels.. 0.00 % 0.40 %

N/A

USD0.07B
C007:F ComStage MDAX UCITS ETF 0.00 % 0.30 %

N/A

USD0.19B
F751:F ComStage Alpha Deutschlan.. 0.00 % 0.69 %

N/A

USD0.01B
EXV7:F iShares STOXX Europe 600 .. 0.00 % 0.46 %

N/A

USD0.12B
EXS3:F iShares MDAX UCITS ETF (D.. 0.00 % 0.51 %

N/A

USD1.47B
ELF1:F Deka MDAX UCITS ETF 0.00 % 0.00 %

N/A

USD0.61B
E907:F Lyxor 1 MDAX UCITS ETF 0.00 % 0.30 %

N/A

USD0.11B
C064:F ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

USD0.01B
XDGM:XETRA Xtrackers Germany Mittels.. 0.00 % 0.40 %

N/A

USD0.06B

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.10% 57% F 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.10% 57% F 65% D
Trailing 12 Months  
Capital Gain 26.21% 61% D- 72% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.21% 61% D- 72% C-
Trailing 5 Years  
Capital Gain 16.15% 58% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.15% 54% F 58% F
Average Annual (5 Year Horizon)  
Capital Gain 0.23% N/A N/A 43% F
Dividend Return 2.02% N/A N/A 58% F
Total Return 2.25% N/A N/A 44% F
Risk Return Profile  
Volatility (Standard Deviation) 16.63% N/A N/A 79% C+
Risk Adjusted Return 13.53% N/A N/A 49% F
Market Capitalization 9.66B 83% B 91% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 17.57 63% D 42% F
Price/Book Ratio 2.41 47% F 37% F
Price / Cash Flow Ratio 10.98 29% F 13% F
EV/EBITDA 11.74 43% F 26% F
Management Effectiveness  
Return on Equity 13.92% 82% B- 84% B
Return on Invested Capital 10.08% 68% D+ 69% D+
Return on Assets 5.27% 78% C+ 86% B
Debt to Equity Ratio 54.24% 43% F 34% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.30 32% F 35% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Higly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.